A amígdala expandida central (EAc) inclui os núcleos central da amígdala (CeA), intersticial lateral da estria terminal (BSTl), intersticial do ramo posterior da comissura anterior (IPAC) e amígdala expandida sublenticular (SLEA). A EAc e a concha do acumbens possuem densa inervação dopaminérgica, implicada em processos motivacionais, e cuja origem foi estudada com a técnica de dupla marcação celular, combinando-se imunofluorescência para o traçador retrógrado Fluoro-Gold e para a tirosina hidroxilase. Nossos resultados indicam que a inervação dopaminérgica do CeA e BSTl é semelhante, se originando em igual proporção da área tegmental ventral (A10) e do núcleo dorsal da rafe/substância cinzenta periaquedutal (A10dc). A inervação dopaminérgica da SLEA, IPAC e concha do acumbens se origina principalmente do grupo A10. Com um anticorpo específico para dopamina vimos que parte da projeção do A10dc para o CeA é de fato dopaminérgica. Os grupos dopaminérgicos diencefálicos não inervam a EAc e a concha do acumbens. / The central extended amygdala (EAc) includes the central amygdaloid nucleus (CeA), lateral bed nucleus of the stria terminalis (BSTl), interstitial nucleus of the posterior limb of the anterior commissure (IPAC) and sublenticular extended amygdala (SLEA). The dopaminergic innervation of the EAc and nucleus accumbens shell is functionally related to motivational processes. Its origin was studied by combining immunofluorescence to tyrosine hydroxylase and Fluoro-Gold, used as retrograde tracer. Our results show that dopaminergic fibers to the CeA and BSTl derive in equal proportion from neurons in ventral tegmental area (A10) and in dorsal raphe nucleus/periaqueductal gray (A10dc). Dopaminergic inputs to SLEA, IPAC and accumbens shell arise mainly from A10 neurons. Using a dopamine antibody, we confirmed that A10dc projections to CeA are in part dopaminergic. Futhermore, the present data indicate that the diencephalic dopaminergic groups do not project to EAc and accumbens shell.

Extensive serotonin (5-HT) fiber innervation throughout the brain corroborates 5-HT’s modulatory role in numerous behaviors including social behavior, emotion regulation, and learning and memory. Abnormal brain 5-HT levels and function are implicated in Autism Spectrum Disorder (ASD) which often co-occurs with other neuropsychiatric conditions. While 5-HT therapeutics are used to treat ASD, variable improvements in symptomatology require further investigation of 5-HT-mediated pathology. Neurexins (Nrxns) are presynaptic cell adhesion molecules that maintain synapse function for proper neural circuit assembly. Given that aberrant Nrxn and 5-HT function independently contribute to signaling pathology and behavioral impairments, it is critical to understand how Nrxn-mediated 5-HT neurotransmission participates in pathological mechanisms underlying ASD. Using fluorescence in situ hybridization, I found that the three Nrxn genes (Nrxn1, Nrxn2, and Nrxn3) are differentially expressed in 5-HT neurons in the dorsal raphe nucleus (DRN) and median raphe nucleus which contain the primary source of 5-HT neurons in the brain. Our lab generated a mouse model with selective deletion of Nrxns in 5-HT neurons to investigate the function of Nrxns in 5-HT signaling. The loss of Nrxns at 5-HT release sites reduced 5-HT release in the DRN and hippocampus and altered 5-HT innervation in specific brain regions. The lack of 5-HTergic Nrxns also reduced sociability and increased depressive-like behavior in males. This mouse model provides mechanisms to shed new light on 5-HT neurotransmission in the generation of complex behaviors.